Skip to content
Delayed ~15 min

OMER OMEROS

Health Care · Russell 2000

Next earnings: Thu 12 Nov 2026 · estimated

What 6 analyst firms say about OMEROS: their latest ratings, price targets and how far the stock is from them. How it works

16.92 USD−0.15 (−0.88%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+67.0%to the avg target 28.25 USD+11.33 USD
Buy 4 · Hold 2 · Sell 0

6 rated views · 7 analyst/firm records · 6 firms

Latest report14 Oct 2026avg report date 6 Aug
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
  • Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)

Recent analyst activity · last 90 days

Our tracked history has 4 reports on OMER from 3 analyst firms in the last 90 days (6 firms in the past year).

Comparing each firm's latest target with its previous one: 1 left it unchanged.

No firm's latest available rating differs from its previous one.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Cantor FitzgeraldOlivia BrayerBuy22 Sep 202622.00 USD
Cantor FitzgeraldOlivia Brayer SaundersBuy14 Oct 202622.00 USD
D Boral CapitalJason KolbertBuy21 Apr 202636.00 USD
H.C. WainwrightBrandon FolkesBuy27 Jul 202633.00 USD
NeedhamSerge BelangerHold15 Sep 2026—
Weiss RatingsUnnamed analyst—8 Oct 2026—
Data feed RESEARCHResearch TeamHold13 Jul 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 05:58 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.